Malta - enska - Medicines Authority

pinewood laboratories ltd ballymacarbry, clonmel, co. tipperary, ireland - amitriptyline hydrochloride - oral solution - amitriptyline hydrochloride 50 mg/5ml - psychoanaleptics

Írland - enska - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline - antidepressants - it is indicated for the treatment of: symptoms of depression (especially where sedation is required), nocturnal enuresis where organic pathology is excluded.

Írland - enska - HPRA (Health Products Regulatory Authority)

syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Írland - enska - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; pregelatinised maize starch; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; purified talc; disodium edetate; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - amitriptyline alphapharm 50mg tablets are indicated only for the maintenance treatment of major depression. (see precautions). nocturnal enuresis where organic pathology has been excluded.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - amitriptyline hydrochloride 50mg;  ;  ;  ; amitriptyline hydrochloride 50mg - film coated tablet - 50 mg - active: amitriptyline hydrochloride 50mg       excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   quinoline yellow titanium dioxide active: amitriptyline hydrochloride 50mg excipient: colloidal silicon dioxide crospovidone hypromellose indigo carmine aluminium lake lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   sunset yellow fcf titanium dioxide - for the treatment of depression.

Írland - enska - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Malta - enska - Medicines Authority

wockhardt uk limited - amitriptyline hydrochloride - oral solution - amitriptyline hydrochloride 50 milligram(s)/5 millilitre - psychoanaleptics

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; lactose monohydrate; crospovidone; maize starch; hypromellose; titanium dioxide; sunset yellow fcf aluminium lake; colloidal anhydrous silica; macrogol 6000; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: colloidal anhydrous silica; macrogol 6000; maize starch; purified talc; crospovidone; magnesium stearate; microcrystalline cellulose; sunset yellow fcf aluminium lake; lactose monohydrate; hypromellose; titanium dioxide; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.